VIMTA LABS
|
The Current P/S Ratio of VIMTA LABS is 5.06.
| Share Price | ₹380.8 | Mar 30,2026 |
| Market Cap | ₹1,702.2 Cr | |
| Sales-TTM | ₹336.1 Cr | TTM-Consolidated Results |
| Price/Sales | 5.06x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of VIMTA LABS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹1,702.2 Cr] as on Mar 30,2026
(/) Sales [ ₹336.1 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 5.06x ]
Thus, for VIMTA LABS , the investors are currently willing to pay '5.06 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of VIMTA LABS !
The chart below summarizes the trend in P/S Ratio of VIMTA LABS over the last five years.
Historical PS (Price/Sales) ratio chart of VIMTA LABS
PS Ratio Performance Analysis for VIMTA LABS
- VIMTA LABS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 2.04x.
- VIMTA LABS 's operated at median p/e ratio of 2.19x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, VIMTA LABS 's p/e ratio peaked in Mar2024 at 3.1x.
- VIMTA LABS 's p/e ratio hit its five-year low in Mar2020 of 0.72x.
How does VIMTA LABS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| VIMTA LABS | 336.1 | 5.06 | 1,702.2 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 7.42 | 421,647.0 |
| DIVIS LABORATORIES LTD | 10,314.0 | 15.31 | 157,862.0 |
| CIPLA LTD | 28,351.1 | 3.48 | 98,795.9 |
| TORRENT PHARMACEUTICALS LTD | 12,742.0 | 11.21 | 142,846.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 3.02 | 104,720.0 |
| MANKIND PHARMA LTD | 13,914.1 | 5.95 | 82,807.2 |
| ZYDUS LIFESCIENCES LTD | 26,089.3 | 3.36 | 87,663.1 |
| LUPIN LTD | 26,150.5 | 4.04 | 105,732.0 |
| AUROBINDO PHARMA LTD | 33,181.9 | 2.28 | 75,690.1 |
| ABBOTT INDIA LTD | 6,824.1 | 8.07 | 55,084.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs VIMTA LABS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.28x |
| Max industry PS | 15.31x |
| Median industry PS | 5.06x |
| Average industry PS | 6.29x |
You may also like the below Video Courses